Sponsor Pipeline

Shandong Tumor Hospital Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 2
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07309185 Adebrelimab Combined With Famitinib and Irinotecan in Advanced Gastric Cancer After… Stomach Neoplasms Recruiting
NCT07320586 Carilizumab and Albumin Paclitaxel for Second-line Treatment of Advanced Gastric Cancer Gastric Cancer Recruiting
NCT06986057 Iparomlimab and Tuvonralimab Combined With Platinum-Based Chemotherapy for Neoadjuvant… Cervical Cancer Not Yet Recruiting
Disease Areas
Cervical Cancer (1) Gastric Cancer (1)
Get alerts when Shandong Tumor Hospital's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free